UNSPSC 51284504: Bambermycin

This classification denotes a polysaccharide antibiotic with the molecular formula C70H109N4O35P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PP922A42V2, chemically known as (2S,3S,4R,5R,6R)-5-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-methyl-5-[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopenten-1-yl)carbamoyl]oxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-4-carbamoyloxy-3-hydroxy-6-[hydroxy-[(2R)-2-hydroxy-3-oxo-3-[(3E,7E,14E)-4,9,9,15,19-pentamethyl-12-methylideneicosa-3,7,14,18-tetraenoxy]propoxy]phosphoryl]oxy-3-methyloxane-2-carboxylic acid but generally known as Bambermycin, which bears US NIH Compound Identifier 6433554.

UNSPSC 51284504 Bambermycin is a Commodity code that in recent state and local procurement activity maps to a broader set of pharmaceutical and medical supply purchases rather than bambermycin specifically. State and local governments soliciting under this code are acquiring naloxone, safe drug deactivation systems, medical and first aid supplies for emergency response, generic pharmaceuticals, and over-the-counter products for health departments, fire departments, and multistate cooperative purchasing programs. The issuing bodies include county health departments, municipal fire rescue divisions, state health and human services agencies, and cooperative purchasing alliances that serve multiple state and local jurisdictions. A notable pattern is the emergence of direct-to-manufacturer and cost-optimization initiatives alongside traditional wholesale-distributed medical supplies procurement.

Geographic activity centers on Florida, Texas, and Minnesota, with multistate cooperative purchasing vehicles extending reach into Oregon and across participating jurisdictions. Recent representative opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2026) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the county community health building; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish contracts for generic pharmaceuticals and OTC products through authorized wholesalers with July 1, 2026 implementation; and the Texas Health and Human Services Commission RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities outside traditional pharmacy benefit manager arrangements.